Biomedix Sponsors Advanced Diagnostic Technology to Enhance Education at Western University of Health Sciences College of Podiatric Medicine

Twin Cities, MN —  Biomedix, a pioneer in medical technology and innovation, has announced a clinical and educational sponsorship with the Western University of Health Sciences (WesternU) College of Podiatric Medicine. Established as part of Western University of Health Sciences, the College of Podiatric Medicine is at the forefront of Read more…

Biomedix is HITRUST r2 Certified

Biomedix Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance

HITRUST r2 Certification validates Biomedix is committed to strong cybersecurity and protecting sensitive data. St. Paul MN, September 3rd, 2024 – Biomedix, a leading provider of front-line diagnostic solutions for healthcare organizations, today announced its Biomedix Xchange and PADnet solutions have earned certified status by HITRUST for information security. HITRUST Read more…

BeamMed MiniOmni Rental Program

Biomedix And BeamMed Announce Strategic Partnership

Innovative Leasing Program for MiniOmni Osteoporosis Screening Twin Cities, MN— August 25th, 2023 —Biomedix, a market-leading medical technology and innovation company, and BeamMed, a developer, manufacturer and marketer of best-in-class bone density assessment solutions, announced a new strategic partnership to assist value-based care organizations close OMW and OSW HEDIS gaps. Read more…

O'Brien ETF 128 being used on a patient to identify peripheral neuropathy

New study confirms the clinical effectiveness of ETF for diabetic foot ulcer development

A study recently published in the Journal of the American Podiatric Medical Association examined the combined utility of a timed vibration test (TVT) combined with monofilament, and compared the effectiveness of using these technologies separately to predict diabetic foot ulcers (DFU) accurately. The study involved 200 patients, 24 which developed Read more…